Zimmer Holdings (NYSE: ZMH) reported earnings on April 26. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), Zimmer Holdings met expectations on revenues and met expectations on earnings per share.

Compared with the prior-year quarter, revenue increased slightly and GAAP earnings per share improved.

Margins contracted across the board.

Revenue details
Zimmer Holdings booked revenue of $1.14 billion. The 22 analysts polled by S&P Capital IQ predicted a top line of $1.14 billion on the same basis. GAAP reported sales were 2.2% higher than the prior-year quarter's $1.12 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Non-GAAP EPS came in at $1.30. The 25 earnings estimates compiled by S&P Capital IQ anticipated $1.30 per share on the same basis. GAAP EPS of $1.17 for Q1 were 8.3% higher than the prior-year quarter's $1.08 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 74.7%, 70 basis points worse than the prior-year quarter. Operating margin was 28.9%, 40 basis points worse than the prior-year quarter. Net margin was 18.4%, 30 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $1.15 billion. On the bottom line, the average EPS estimate is $1.32.

Next year's average estimate for revenue is $4.54 billion. The average EPS estimate is $5.26.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 602 members out of 631 rating the stock outperform, and 29 members rating it underperform. Among 222 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 214 give Zimmer Holdings a green thumbs-up, and eight give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Zimmer Holdings is outperform, with an average price target of $66.75.

The health-care investing landscape is littered with also-rans and a few major winners. Is Zimmer Holdings the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will be a phenomenal success over the next few years. Get instant access to this free report.